Skip to search formSkip to main contentSkip to account menu

CD20-targeted Polypeptide TRU-015

Known as: TRU-015 
A proprietary antibody-based single-chain polypeptide with B cell-depleting activity. Significantly smaller than a whole antibody, CD20-targeted… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Background In a Phase 2b double-blind, placebo-controlled randomized clinical trial, 222 subjects with seropositive, active… 
2011
2011
1. A method of treating a human suffering from cancer comprising administering to a human anti-CD200 antibody or CD200-binding… 
Review
2009
Review
2009
  • Dr. I.H. Tarner
  • 2009
  • Corpus ID: 25120515
ZusammenfassungDer klinische Erfolg der Depletierung von B-Zellen durch den Anti-CD20-Antikörper Rituximab hat eine neue Ära in… 
2009
2009
D’importants progres realises durant les deux dernieres decennies dans le domaine du genie moleculaire des proteines ont permis l… 
2008
2008
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2007
2007
Agomelatine, AGRO-100, AIDSVAX gp120 B/E, alfimeprase, aliskiren fumarate, ALVAC vCP1452, alvocidib hydrochloride, ambrisentan… 
2007
2007
Background IL-21 is secreted by activated T cells and modulates immune cell functions with both proinflammatory and anti…